1. Shabrish S, Naorem LD, Mohanty S, Kumar R, Lopes R, Akhter N, Khare NK, Joshi R, Sawant R, Raghuram GV, Jadhav V, Shinde S, Chandrani P, Mittra I (2025). Induction of cancer stem cells from mouse fibroblasts. Scientific Reports. 15(1): 25489

2. Solanki SL, Sanapala V, Ambulkar RP, Agarwal V, Saklani AP, Maheshwari A (2025). A Prospective Observational Study on Compliance with Enhanced Recovery Pathways and Their Impact on Postoperative Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Journal of Gastrointestinal Cancer. 56(1):155

3. Laskar SG, Mohanty S, Sinha S, Kumar A, Pantvaidya G, Thiagarajan S, Budrukkar A, Swain M, Deshmukh A, Nair D, Vaish R, Tuljapurkar V, Dravid C, Nair S, Joshi P, Shetty R, Singh AG, Chaturvedi P (2025). Adjuvant external beam radiotherapy in differentiated thyroid cancers: An audit of clinical practice, adapting to new evidence. Head Neck.

4. Laskar SG, Sinha S, Jeeva M, Gupta M, Karmakar S, Kumar A, Mohanty S, Mahajan P, Timmanpyati S, Balaji A, Budrukkar A, Swain M, Khan F, Pantvaidya G, Deshmukh A, Nair D, Chaukar D, Pai P, Thiagarajan S, Vaish R, Tuljapurkar V, Chaturvedi P (2025). Prophylactic Versus Reactive (PvR) feeding in patients undergoing (Chemo)radiation in head and neck cancers: Results of a phase III randomized controlled trial. Head Neck.

5. Mirgh S, Bagal B, Punatar S, Gokarn A, Jindal N, Chichra A, Nayak L, Hiregoudar S, Poojary M, Saha S, Parab S, Ojha S, Tembhare P, Patkar N, Rajpal S, Chatterjee G, Mathew L, Subramanian P, Khattry N (2025). Moving byond G-CSF mobilization-learning from a 15-Year experience of different stem cell mobilization regimens in multiple myeloma. Cancer Medicine. 14(14):e71068.

6. Yahya S, Pushpanathan S, Jan S, Chaudhary N, Parray R, Gandhi KA, Thangavel K, Krishnan K, Sudhandiran G (2025). Development and characterization of pegylated Fe3O4-CAPE magnetic nanoparticles for targeted therapy and hyperthermia treatment of colorectal cancer. Scientific Reports 215(1):26008

7. Trivedi V, Noronha V, Bal M, Chandrani P, Poojary D, Saldanha E, Choughule A, Pange P, Gupta V, Menon N, Patil V, Shah M, Chaturvedi P, Prabhash K, Dutt A (2025). Comprehensive genomic profiling of anaplastic thyroid cancer identifies alterations in THRA, a potential modifier of cellular plasticity. JCO Global Oncology. 11:e2400610.

Lung Cancer Explorer (LCE) is a database specifically dedicated to lung cancer. It enables researchers and clinicians to explore lung cancer data and perform various analyses.

Knol JC, Lyu M, Böttger F, Nunes Monteiro M, Pham TV, Rolfs F, Vallés-Martí A, Schelfhorst T, de Goeij-de Haas RR, Bijnsdorp IV, Wang S, Zhang F, A J, Westerman BA, Sitek B, Lehtiö J, Koster J, IJzermans JNM, van Laarhoven HWM, Bijlsma MF, Medema JP, Henneman AA, Piersma SR, Brakenhoff RH, Cloos J, Cordo' V, de Jong D, Kazemier G, Koppers-Lalic D, Labots M, Le Large TYS, Martens JWM, Meijerink JPP, Mumtaz M, Scheepbouwer C, Kibbelaar RE, Noske DP, Steenbergen RDM, van Grieken NCT, van Houdt W, Giovannetti E, van Leenders GJLH, Jonkers J, Liu T, Yan M, Zhan X, Guo T, Jimenez CR (2025). The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets. Cancer Cell. 43(7):1328-1346.e8.

In 2012, two seminal studies revealed the presence of mutations affecting the histone H3 genes in paediatric high-grade gliomas, including glioblastomas.

2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)